|
||
Journal of Experimental Medicine, Vol 170, 1051-1056, Copyright © 1989 by Rockefeller University Press
ARTICLES |
K Gould, J Cossins, J Bastin, GG Brownlee and A Townsend
Sir William Dunn School of Pathology, University of Oxford, United Kingdom.
A recombinant vaccinia has been designed to express amino acids 366-379 of influenza nucleoprotein, previously shown to be the minimal epitope recognized by a class I-restricted cytotoxic T cell clone. Target cells infected with the recombinant vaccinia virus expressing this peptide are recognized by CTL as efficiently as target cells expressing the complete nucleoprotein. The results imply the existence of a peptide transport system that constitutively passes the products of degraded proteins from the cytoplasm into a membrane-bound compartment of the cell.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|